Welch & Forbes LLC lowered its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 10.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,064 shares of the semiconductor company’s stock after selling 3,345 shares during the period. Welch & Forbes LLC’s holdings in Synopsys were worth $13,076,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in SNPS. Elevation Wealth Partners LLC lifted its position in Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after buying an additional 27 shares in the last quarter. Osbon Capital Management LLC acquired a new position in shares of Synopsys during the 2nd quarter worth about $25,000. IMG Wealth Management Inc. acquired a new position in shares of Synopsys during the 2nd quarter worth about $28,000. GK Wealth Management LLC bought a new position in shares of Synopsys in the 3rd quarter valued at about $28,000. Finally, Geneos Wealth Management Inc. grew its holdings in shares of Synopsys by 151.5% in the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after acquiring an additional 50 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Performance
NASDAQ SNPS opened at $466.97 on Tuesday. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The firm’s fifty day moving average price is $442.10 and its two-hundred day moving average price is $442.00. Synopsys, Inc. has a 1 year low of $362.55 and a 1 year high of $539.48. The firm has a market capitalization of $89.49 billion, a P/E ratio of 82.50, a price-to-earnings-growth ratio of 1.47 and a beta of 1.18.
Synopsys declared that its board has authorized a share repurchase program on Monday, October 5th that allows the company to buy back $1 billion in shares. This buyback authorization allows the semiconductor company to repurchase up to 1.1% of its stock through open market purchases. Share buyback programs are often a sign that the company’s leadership believes its shares are undervalued.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on SNPS shares. Needham & Company LLC lifted their target price on Synopsys from $580.00 to $620.00 and gave the company a “buy” rating in a research report on Monday, October 12th. Rosenblatt Securities upped their target price on Synopsys from $575.00 to $620.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Rothschild & Co Redburn reduced their price target on Synopsys from $560.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 23rd. Roth Capital upgraded Synopsys to a “buy” rating in a research note on Friday, September 25th. Finally, Zacks Research upgraded Synopsys from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 2nd. One research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $575.00.
Read Our Latest Report on Synopsys
Insider Activity
In related news, CFO Sudhindra Kankanwadi sold 9,170 shares of Synopsys stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the transaction, the chief financial officer owned 22,717 shares in the company, valued at approximately $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Janet Lee sold 1,144 shares of the business’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total value of $574,882.88. Following the transaction, the insider directly owned 16,534 shares in the company, valued at approximately $8,308,665.68. This trade represents a 6.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 117,163 shares of company stock valued at $51,366,457 in the last 90 days. 0.56% of the stock is owned by company insiders.
About Synopsys
Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.
The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
Featured Articles
- Five stocks we like better than Synopsys
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
